Edoxudine

Edoxudine
Clinical data
ATC code	D06BB09 (WHO) ;
Legal status
Legal status	In general: ℞ (Prescription only);
Identifiers
	IUPAC name 5-ethyl-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione;
CAS Number	15176-29-1 ;
PubChem CID	66377;
DrugBank	DB13421 ;
ChemSpider	59752 ;
UNII	15ZQM81Y3R;
ChEMBL	ChEMBL318153 ;
CompTox Dashboard (EPA)	DTXSID4045890 ;
ECHA InfoCard	100.035.645
Chemical and physical data
Formula	C11H16N2O5
Molar mass	256.258 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C/1NC(=O)N(\C=C\1CC)[C@@H]2O[C@@H]([C@@H](O)C2)CO;
	InChI InChI=1S/C11H16N2O5/c1-2-6-4-13(11(17)12-10(6)16)9-3-7(15)8(5-14)18-9/h4,7-9,14-15H,2-3,5H2,1H3,(H,12,16,17)/t7-,8+,9+/m0/s1 ; Key:XACKNLSZYYIACO-DJLDLDEBSA-N ;
	(what is this?) (verify)

Edoxudine (or edoxudin) is an antiviral drug. It is an analog of thymidine, a nucleoside.

It has shown effectiveness against herpes simplex virus.^[1]

References

↑ Hamuy R, Berman B (December 1998). "Topical antiviral agents for herpes simplex virus infections". Drugs of Today. 34 (12): 1013–1025. doi:10.1358/dot.1998.34.12.487486. PMID 14743269.

This antiinfective drug article is a stub. You can help Wikipedia by adding missing information.

This dermatologic drug article is a stub. You can help Wikipedia by adding missing information.